Breaking News
November 19, 2018 - Scientists equip new virus that kills carcinoma cells with protein
November 19, 2018 - Protein in cell membranes of sperm plays key role in finding their way to eggs
November 19, 2018 - Parents who decline flu vaccination for their child may be exposed to limited information
November 19, 2018 - Mirati Presents Data From Ongoing Phase 2 Clinical Trial Of Mocetinostat In Combination With Durvalumab At The SITC 33rd Annual Meeting
November 19, 2018 - FDA warns of common diabetes meds’ link to dangerous genital infection
November 19, 2018 - New methods for preserving shoulder function, quality of life in breast cancer patients
November 19, 2018 - Surprising discovery about BH4 may rekindle interest in once-promising pathway
November 19, 2018 - Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections
November 19, 2018 - Beating breast cancer only to die of opioid use – a sad Appalachian story
November 19, 2018 - Workplace bullying or violence linked to higher risk of cardiovascular problems
November 19, 2018 - Changes in Risk Indicators of MetS Severity Tied to T2DM Risk
November 19, 2018 - ‘Game-changing’ skin sensor could improve life for a million hydrocephalus patients
November 19, 2018 - Alcohol ads on social media sites with pro-drinking comments increase desire to drink
November 19, 2018 - Neural networks could replace marker genes in RNA sequencing
November 19, 2018 - Obese adolescents feel less food enjoyment than those with normal weight, study reveals
November 18, 2018 - Goodbye ‘Gluten-Free’? Celiac Disease Vaccine May Make It Possible
November 18, 2018 - Skin ages when the main cells in the dermis lose their identity and function
November 18, 2018 - Rainforest vine compound makes pancreatic cancer cells susceptible to nutrient starvation
November 18, 2018 - A new mechanism in the control of inflammation
November 18, 2018 - Age-related decline in abstract reasoning ability predicts depressive symptoms over time
November 18, 2018 - Scientists succeed in increasing stability, biocompatibility of light-transducing nanoparticles
November 18, 2018 - Sugar, a ‘sweet’ tool to understand brain injuries
November 18, 2018 - Pharmacist-Led Effort Cuts Inappropriate Rx in Older Adults
November 18, 2018 - Novel discovery could lead to new cancer, autoimmune disease therapy
November 18, 2018 - AHA and ADA launch new initiative to help people with type 2 diabetes reduce heart disease risk
November 18, 2018 - Balanced production of pro and anti-inflammatory cytokines at two years of age protects against malaria
November 18, 2018 - New pharmacological agent shows promise for prevention of heart rhythm disorders
November 18, 2018 - All That Social Media May Boost Loneliness, Not Banish It
November 18, 2018 - Scientists shine new light on link between obesity and cancer
November 18, 2018 - Risk factors for cardiovascular disease closely track with changes in diet patterns
November 18, 2018 - Biogen Scoops Sixth Prix Galien Award with UK Win for Life-Changing Rare Disease Medicine
November 18, 2018 - Detectable HIV-1 in treated human liver cells found to be inert
November 18, 2018 - Using light to control crucial step in embryonic development
November 18, 2018 - Unusual case of father-to-son HIV transmission reported
November 18, 2018 - FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
November 18, 2018 - Poverty blamed on widening north-south gap in young adult deaths in England
November 18, 2018 - Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows
November 18, 2018 - Consensus Statement Issued on Management of Foot, Ankle Gout
November 18, 2018 - Fine particle air pollution is a public health emergency hiding in plain sight
November 18, 2018 - In-hospital mortality higher among patients with drug-resistant infections
November 17, 2018 - Research shines new, explanatory light on link between obesity and cancer
November 17, 2018 - FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings
November 17, 2018 - Tracking Preemies’ Head Size May Yield IQ Clues
November 17, 2018 - Scientists call for unified standards in 3-D genome and epigenetic data
November 17, 2018 - Lab Innovations 2018 has beaten all records by attracting 3,113 attendees
November 17, 2018 - New strategy to hinder emergence of antimicrobial-resistant pathogens
November 17, 2018 - Sexuality education before age 18 may reduce risk of sexual assault in college
November 17, 2018 - Reducing cellular proliferation could help deplete HIV reservoir and lead to a functional cure
November 17, 2018 - New model of FSHD could be useful to study effectiveness of experimental therapeutics
November 17, 2018 - FDA approves antibacterial drug to treat travelers’ diarrhea
November 17, 2018 - Lab Innovations 2018 confirmed as a major hit with visitors, exhibitors and speakers
November 17, 2018 - Largest parasitic worm genetic study hatches novel treatment possibilities
November 17, 2018 - UCLA biologists uncover how head injuries can lead to serious brain disorders
November 17, 2018 - Static and dynamic physical activities offer varying protection against heart disease
November 17, 2018 - Obesity significantly increases risk of Type 2 diabetes and coronary artery disease
November 17, 2018 - New method to analyze cell membrane complexes could revolutionize the way we study diseases
November 17, 2018 - Researchers show how proteins interact in hypoxic conditions to facilitate mitochondrial fission
November 17, 2018 - People with rare cancers can benefit from genomic profiling, shows research
November 17, 2018 - NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach
November 17, 2018 - Four-in-one antibody used to fight flu shows promise in mice
November 17, 2018 - New approach allows pathogens to be starved by blocking important enzymes
November 17, 2018 - Higher body mass index could cause depression even without health problems
November 17, 2018 - Protein which plays role in sensing cell damage serves as new target to treat pulmonary hypertension
November 17, 2018 - FDA Approves Adcetris (brentuximab vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas
November 17, 2018 - ID specialist input improves outcomes for outpatient parenteral antimicrobial therapy
November 17, 2018 - UT Southwestern scientists selected to receive 2019 Edith and Peter O’Donnell Awards
November 17, 2018 - New clinical algorithm to help individuals manage type 2 diabetes when fasting during Ramadan
November 17, 2018 - Researchers identify LZTR1 as evolutionarily conserved component of RAS pathway
November 17, 2018 - Heart Disease Leading Cause of Death in Low-Income Counties
November 17, 2018 - Estrogen Levels Test: MedlinePlus Lab Test Information
November 17, 2018 - Research reveals link between immunity, diabetes
November 17, 2018 - Research shows how to achieve improved smoking cessation outcomes within California’s Medicaid population
November 17, 2018 - New study finds less understanding and implementation of patient engagement
November 17, 2018 - New shoe insole technology could help diabetic ulcers heal better while walking
November 17, 2018 - New method to extend cell division and immortalization of avian-derived cells
November 17, 2018 - Australian Academy of Science urges parents to vaccinate children against meningococcal disease
November 17, 2018 - Hot water treatment may help improve inflammation and metabolism in sedentary people
November 17, 2018 - Researchers produce 3D chemical maps of small biological samples
November 17, 2018 - Must Blood Pressure Rise Wth Age? Remote Tribes Hold Clues
November 17, 2018 - Noonan Syndrome
5 Questions: Paul Blumenthal on contraception in India | News Center

5 Questions: Paul Blumenthal on contraception in India | News Center

image_pdfDownload PDFimage_print

In the past 10 years, the percentage of women who use intrauterine devices in the United States has leapt from less than 1 percent to nearly 20 percent. But at the international level, those figures are much lower.

Paul Blumenthal, MD, MPH, professor of obstetrics and gynecology at the School of Medicine, focuses much of his work on family planning in developing countries, many of which do not have broad access to long-acting contraception. Blumenthal’s latest paper, published in collaboration with Population Services International, describes the implementation of a new device used to insert IUDs in women immediately after they give birth, and he hopes it will help health care professionals in developing countries provide broader access to long-acting contraceptives.

The idea behind Blumenthal’s postpartum IUD inserter, which comes with the IUD packaged inside it, is to simplify and streamline the process of providing women with birth control. In a clinical trial with 500 participants, health care providers in India used either Blumenthal’s IUD inserter or the traditional forceps method to place the contraceptive, comparing their efficacy, ease and safety.

A paper detailing the clinical trial was published online May 8 in Contraception. Blumenthal is the senior author.

Blumenthal’s goal is to bring simple, affordable contraception to the masses — particularly in developing countries. Establishing the inserter’s legitimacy in this trial, Blumenthal said, is a step in that direction. Recently, he spoke with science writer Hanae Armitage about the details of this work, the drivers behind it and how he hopes to see it pan out on an international scale.

Q: What motivated your team to create this device? Why opt to support IUD usage as opposed to a different contraceptive option?

Blumenthal: IUDs are an excellent method of contraception, and that’s increasingly recognized by both providers and patients around the world. They’re extremely effective. They’re a “forgettable” form of contraception — that is, they’re inserted and they don’t need tending to or replacement for somewhere between five and 12 years, which also makes them very cost-effective.

In a postpartum setting, there are actually a lot of serendipities that make it an optimal time for IUD insertion. Since the woman has just delivered her baby, both she and her provider are already in the same place at the same time; no one has to make a special trip to have the IUD inserted. Studies have shown that, among women who want an IUD for contraception, the number of individuals who have an IUD one year after delivering a baby are higher if the woman gets the IUD postpartum, rather than if they wait to have it inserted later.

So, we thought if we can make this convenient, simple and intuitive, then maybe we could reduce barriers for providers, who could then have better access to providing postpartum IUDs. Furthermore, in some developing countries, the special forceps often recommended to insert IUDs right after birth can be hard to come by. With the dedicated inserter, the IUD is already packaged in the instrument, and it’s just a “grab-and-go” process.

Q: Why did you decide to conduct this study in India and how did the health care providers react to your new device?

Blumenthal: India has one of the most well-developed programs for postpartum IUDs. For example, in obstetrics and gynecology, physicians are required to learn how to insert IUDs postpartum because the Indian government and the community of OB-GYNs in India feel that it’s an important part of provision of contraception. So, we thought, “OK, if you’re going to do a lot of something, then why wouldn’t you have something specifically designed to do it?” One analogy we often use is, if you’re going press garlic, you don’t smash it with a hammer, you want to use a garlic press. It’s the same idea here: We want to make it precise, and we want to simplify the process.

When we introduced the inserter, in general the feedback was very positive. Most who used the inserter said that it was easy to use. Now, they also said that it was easy to use the traditional forceps — but that doesn’t take away from the success of the inserter. This study is a win for broad dissemination of the tool in India. And now, it’s even been approved by the Drug Controller General of India for broad public and private use.

Q: With the Drug Controller General of India’s approval for commercial use, how will you scale up the process in India, and do you plan to bring this option to women in other developing countries as well?

Blumenthal: We’re working with a third-party company called Pregna International. They’re based in India, and they manufacture IUDs used in programs worldwide. Now with commercial approval, Pregna can market this inserter to the public and private sector in India and reach potentially millions of women. At the same time, other nongovernmental organizations that are working in the family planning area can also recommend this to their programs in India, and that will likely enhance the public-sector programs as well. Currently, the IUD inserter is under review by the United Nations Family Planning Assistance Program, and we hope that this publication will serve to help the UNFPA in its deliberation. Hopefully, that will allow for prequalification of the device, so that it can be used in UNFPA publicly-funded programs that reach other developing countries in sub-Saharan Africa and South Asia.

Q: Do you have plans to integrate the device into developed countries like the United States, too?

Blumenthal: We don’t have plans at present, specifically because Pregna doesn’t market its IUDs in the U.S. For a company like Pregna, it’s likely too costly to have their device approved by the Food and Drug Administration, which requires a significant amount of capital to achieve. However, I’m sure that Pregna would be open to working with a U.S. company or any other company to adapt the technology of this relatively simple inserter to IUDs that are very similar.

Q: Are you working on other projects that likewise empower contraceptive options?

Blumenthal: We’re always working on these kinds of projects. One of our family planning fellows is looking at a unique combination of an emergency contraceptive product and another available drug in the U.S. to see if it’s possible to make an “on-demand” contraception. So for example, if a woman has intercourse infrequently, she may not feel like she needs to take a pill every day, or might not need to have an IUD, but she may want to have a contraception method she can use when she wants. So, theoretically, a woman could take this pill once during the course of a cycle, at any time during the cycle, and that would effectively act as contraception. Our tagline here could really be “simplicity and precision.” We want to empower women with options, access and the ability to choose what’s right for their lives and body, at the exact time that they want it.

About author

Related Articles